Zelira Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - Industrial WAZelira Therapeutics was formerly known as Zelda Therapeutics, a Perth-based biotechnology company formed to bring together some of the world’s leading researchers and clinicians active in the study and use of medicinal cannabis to treat a variety of ailments.
The company listed on the ASX in October 2016, through the reverse takeover of Gleneagle Gold.
In December 2019, Zelda Therapeutics acquired Ilera Therapeutics and changed its name to Zelira Therapeutics.
Contact Details
Level 3, 101 St Georges Terrace, PERTH WA 6000
08 6558 0886
Lists and Charts
Public Companies - Industrial WA list sponsored by
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1101st | Zelira Therapeutics | -17% | -42% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Zelira Therapeutics | $1.0m |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Greg Blake, Executive Director | 14 Aug 2024 |
| NEW ROLE: Donna O?Donnell, | 08 Jan 2024 |
| NEWS: Tagged in Board Moves May 31 to June 2, 2023 | 07 Jun 2023 |
| NEW ROLE: Donna Gentile O'Donnell, Non-Executive Director | 07 Jun 2023 |
| ECM DEAL: New deal has been added | 21 Apr 2023 |
| NEWS: Tagged in Board Moves February 20, 2023 | 20 Feb 2023 |
| NEW ROLE: Greg Blake, Vice President & Global Head of Commercial & Partnering, Executive Director since 2023 | 20 Feb 2023 |
| NEWS: Tagged in Board Moves May 12, 2022 | 12 May 2022 |
| NEWS: Tagged in Board Moves January 31, 2022 | 31 Jan 2022 |
